iShares LifePath Target Date 2055 ETF
ITDG
1 hedge funds and large institutions have $295K invested in iShares LifePath Target Date 2055 ETF in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
67.17% less ownership
Funds ownership: 74.31% → 7.14% (-67%)
85% less capital invested
Capital invested by funds: $2.03M → $295K (-$1.74M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.12M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$664K |
ITDG Hedge Fund Activity: Q1 2024 in Review
1 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in iShares LifePath Target Date 2055 ETF (ITDG) for Q1 2024, worth a combined $295K — down 85% from $2.03M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ITDG and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was BlackRock, cutting an estimated $1.12M.
- 1 institutional investor held iShares LifePath Target Date 2055 ETF (ITDG) as of Q1 2024, down from 2 in Q4 2023.
- Funds reported $295K of iShares LifePath Target Date 2055 ETF stock for Q1 2024, down 85% quarter-over-quarter.
- 0 funds opened new iShares LifePath Target Date 2055 ETF positions in Q1 2024 and 1 closed out, a net change of -1 holder.
- The largest iShares LifePath Target Date 2055 ETF seller in Q1 2024 was BlackRock, an estimated $1.12M sold.
Based on aggregated 13F filings for Q1 2024.